Overview

Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)

Status:
Completed

Trial end date:
2009-02-01

Target enrollment:

Participant gender:

Summary

Study is to compare antifungal prophylaxis of Voriconazole and Itraconazole in subjects who have had a Stem Cell Transplant. The success of the end point will be measured using evidence of Infection, drug compliance and survival.

Phase:

Phase 3

Details

Lead Sponsor:

Pfizer

Treatments:

Hydroxyitraconazole
Itraconazole
Voriconazole